Bevacizumab/Cisplatin/Paclitaxel/Pembrolizumab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of bevacizumab, cisplatin, paclitaxel and pembrolizumab that may be used in the treatment of cervical, vulvar, and vaginal cancer.
**Synonyms:** - Avastin/Cisplatin/Taxol/Keytruda - Bevacizumab-Cisplatin-Paclitaxel-Pembrolizumab - Bevacizumab/Cisplatin/Paclitaxel/Pembrolizumab - Cisplatin, Paclitaxel, Bevacizumab, Pembrolizumab - Cisplatin, Paclitaxel, Bevacizumab-adcd, Pembrolizumab - Cisplatin, Paclitaxel, Bevacizumab-awwb, Pembrolizumab - Cisplatin, Paclitaxel, Bevacizumab-aybi, Pembrolizumab - Cisplatin, Paclitaxel, Bevacizumab-bvzr, Pembrolizumab - Cisplatin, Paclitaxel, Bevacizumab-equi, Pembrolizumab - Cisplatin, Paclitaxel, Bevacizumab-maly, Pembrolizumab - Cisplatin, Paclitaxel, Bevacizumab-onbe, Pembrolizumab - Cisplatin, Paclitaxel, Bevacizumab-tnjn, Pembrolizumab - Paclitaxel/Cisplatin Plus Pembrolizumab/Bevacizumab
/api/v1/systems/nci_thesaurus/nodes/C205356Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.